Home Cradle

Cradle

In operation
Series B
Biotechnology Researcher
Basic
Enterprise Profile

Basic Information

Under the leadership of CEO Stef van Grieken, Cradle enables scientists to "reverse engineer" proteins to give them specific desired properties and has built a working platform that is already being used by many early design partners. Its self-learning, self-improving generative machine learning model draws on the latest advances in "natural language processing" to predict which parts of the genetic code of proteins biologists need to change, thereby increasing the chances for scientists to achieve their desired experimental results.
Cradle Bio B.V.
Amsterdam,NorthHolland,Netherlands
15~50 people
January 01, 2021
--

Enterprise Profile

Industrial Sector
Information Technology Vendors CRO
Technology
Machine Learning Natural Language Processing Protein Technology
Application Scenarios
AI+Pharmaceuticals